000			01665 a2200421 4500
005			20250516163940.0
264		0	_c20140813
008			201408s 0 0 eng d
022			_a1559-2030
024	7		_a10.1016/j.cct.2013.08.003 _2doi
040			_aNLM _beng _cNLM
100	1		_aWangelin, Bethany C
245	0	0	_aEnhancing exposure therapy for PTSD with yohimbine HCL: protocol for a double-blind, randomized controlled study implementing subjective and objective measures of treatment outcome. _h[electronic resource]
260			_bContemporary clinical trials _cNov 2013
300			_a319-26 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, Non-P.H.S.
650	0	4	_aAdrenergic alpha-2 Receptor Antagonists _xtherapeutic use
650	0	4	_aClinical Protocols
650	0	4	_aDouble-Blind Method
650	0	4	_aGalvanic Skin Response _xphysiology
650	0	4	_aHeart Rate _xphysiology
650	0	4	_aHumans
650	0	4	_aImagery, Psychotherapy _xmethods
650	0	4	_aImplosive Therapy _xmethods
650	0	4	_aIraq War, 2003-2011
650	0	4	_aMale
650	0	4	_aPsychiatric Status Rating Scales
650	0	4	_aStress Disorders, Post-Traumatic _xphysiopathology
650	0	4	_aTreatment Outcome
650	0	4	_aUnited States
650	0	4	_aVeterans _xpsychology
650	0	4	_aYohimbine _xtherapeutic use
700	1		_aPowers, Mark B
700	1		_aSmits, Jasper A J
700	1		_aTuerk, Peter W
773	0		_tContemporary clinical trials _gvol. 36 _gno. 2 _gp. 319-26
856	4	0	_uhttps://doi.org/10.1016/j.cct.2013.08.003 _zAvailable from publisher's website
999			_c22998745 _d22998745